Biomeme is a biotechnology company that was founded in 2012. The company operates within the Biotechnology and Health Care industries. Their recent financial boost came in the form of a Convertible Note investment on 11 March 2024, with Robin Hood Ventures being the participating investors. With their focus on leveraging technology in the biotech and healthcare sectors, Biomeme continues to attract attention and funding from notable investors.
Biomeme, Inc.
DNA analysis in the palm of your hand - anyone, anywhere.
Founded 2012
Philadelphia, United States
71 employees
Convertible Note
Total: $1.42M
Biotechnology, Digital Health +2
Philadelphia, United States
71 employees
Convertible Note
Total: $1.42M
Biotechnology, Digital Health +2
General Information
Company Name
Biomeme, Inc.
Founded Year
2012
Location
Philadelphia, United States
Philadelphia, United States
Employees
71
Industries
Biotechnology, Digital Health, Health Care +1
Funding Stage
Convertible Note
BounceWatch is an independent company data service, not affiliated with Biomeme, Inc.. To contact Biomeme, Inc., visit biomeme.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Biomeme, Inc. compare?
A PDF of Biomeme, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Biomeme, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Biomeme, Inc.
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Convertible Note | Undisclosed | 1 |
|
11 Mar 2024 |
| Venture Round | Undisclosed | 1 |
|
01 Jan 2022 |
| Convertible Note | $131.63K | 1 |
|
29 Jul 2020 |
| Non Equity Assistance | Undisclosed | 1 |
|
03 Apr 2016 |
| Debt Financing | $992.80K | - |
|
29 Jan 2014 |
| Equity Crowdfunding | $300.00K | - |
|
23 Dec 2013 |
| Seed Round | Undisclosed | 1 |
|
15 Jul 2013 |
FAQ About Biomeme, Inc.
DNA analysis in the palm of your hand - anyone, anywhere.
Biomeme, Inc. was founded in 2012.
Biomeme, Inc. is headquartered in Philadelphia, United States.
Biomeme, Inc. operates in Biotechnology, Digital Health, Health Care and Privacy and Security.
Biomeme, Inc. has approximately 71 employees.
Biomeme, Inc. has completed 7 funding rounds, raising a total of $1.42M. The latest funding stage is Convertible Note.
We're actively collecting intelligence on Biomeme, Inc..
Source: BounceWatch company record for Biomeme, Inc., https://bouncewatch.com/company/biomeme, updated 30 December 2024. When citing, please name BounceWatch and link this page.
